Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma

por Valera, Vladimir A., Walter, Beatriz A., Linehan, W. Marston, Merino, Maria J.
Publicado 2011

Comprehensive microRNA Profiling of Prostate Cancer

por Walter, Beatriz A., Valera, Vladimir A., Pinto, Peter A., Merino, Maria J.
Publicado 2013

miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis

por Walter, Beatriz A., Gómez-Macias, Gabriela, Valera, Vladimir A., Sobel, Mark, Merino, Maria J.
Publicado 2011

microRNA Expression Profiling in Young Prostate Cancer Patients

por Valera, Vladimir A., Parra-Medina, Rafael, Walter, Beatriz A., Pinto, Peter, Merino, Maria J
Publicado 2020

Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization

por Hong, Seung-Beom, Oh, HyoungBin, Valera, Vladimir A., Baba, Masaya, Schmidt, Laura S., Linehan, W. Marston
Publicado 2010

Molecular Sub-Classification of Renal Epithelial Tumors Using Meta-Analysis of Gene Expression Microarrays

por Sanford, Thomas, Chung, Paul H., Reinish, Ariel, Valera, Vladimir, Srinivasan, Ramaprasad, Linehan, W. Marston, Bratslavsky, Gennady
Publicado 2011

Protein Expression Profiling in the Spectrum of Renal Cell Carcinomas

por Valera, Vladimir A, Li-Ning-T, Elsa, Walter, Beatriz A, Roberts, David D., Linehan, W M, Merino, Maria J
Publicado 2010

Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling

por Hong, Seung-Beom, Oh, HyoungBin, Valera, Vladimir A, Stull, Jaime, Ngo, Duy-Tan, Baba, Masaya, Merino, Maria J, Linehan, W Marston, Schmidt, Laura S
Publicado 2010

Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells

por Holland, Elizabeth M., Gonzalez, Corina, Levy, Elliot, Valera, Vladimir A., Chalfin, Heather, Klicka-Skeels, Jacquelyn, Yates, Bonnie, Kleiner, David E., Hadigan, Colleen, Dave, Hema, Shalabi, Haneen, Hickstein, Dennis D., Su, Helen C., Grimley, Michael, Freeman, Alexandra F., Shah, Nirali N.
Publicado 2021

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

por Girardi, Daniel M., Niglio, Scot A., Mortazavi, Amir, Nadal, Rosa, Lara, Primo, Pal, Sumanta K., Saraiya, Biren, Cordes, Lisa, Ley, Lisa, Ortiz, Olena Sierra, Cadena, Jacqueline, Diaz, Carlos, Bagheri, Hadi, Redd, Bernadette, Steinberg, Seth M., Costello, Rene, Chan, Keith S., Lee, Min-Jung, Lee, Sunmin, Yu, Yunkai, Gurram, Sandeep, Chalfin, Heather J., Valera, Vladimir, Figg, William D., Merino, Maria, Toubaji, Antoun, Streicher, Howard, Wright, John J., Sharon, Elad, Parnes, Howard L., Ning, Yang-Min, Bottaro, Donald P., Cao, Liang, Trepel, Jane B., Apolo, Andrea B.
Publicado 2022

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

por Apolo, Andrea B., Nadal, Rosa, Girardi, Daniel M., Niglio, Scot A., Ley, Lisa, Cordes, Lisa M., Steinberg, Seth M., Sierra Ortiz, Olena, Cadena, Jacqueline, Diaz, Carlos, Mallek, Marissa, Davarpanah, Nicole N., Costello, Rene, Trepel, Jane B., Lee, Min-Jung, Merino, Maria J., Bagheri, Mohammad Hadi, Monk, Paul, Figg, William D., Gulley, James L., Agarwal, Piyush K., Valera, Vladimir, Chalfin, Heather J., Jones, Jennifer, Streicher, Howard, Wright, John J., Ning, Yangmin M., Parnes, Howard L., Dahut, William L., Bottaro, Donald P., Lara, Primo N., Saraiya, Biren, Pal, Sumanta K., Stein, Mark N., Mortazavi, Amir
Publicado 2020